Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Today: From Yahoo Finance
BioAdaptives, Inc.
VeganHepPlusTM is Designed to Detoxify the Liver and Support Healthy Function
The American Association for the Study of Liver Diseases Predict Increase in Chronic Liver Disease Over the Next 25 Years
The Rise of Air Pollution Poses a Significant Threat to Liver Health
LAS VEGAS, NV, Nov. 16, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioAdaptives, Inc. (OTC: BDPT), a leading manufacturer and distributor of innovative, all-natural dietary supplements, highlights the importance of liver support as experts predict a steady rise of the most common form of chronic liver disease over the next 25 years.
Scientists presenting at The Liver Meeting, held by the American Association for the Study of Liver Diseases this week, predict nearly twice as many liver cancers and almost triple the need for liver transplantation by 2050. Researchers also focused on increases in air pollution and the impact this will have on liver disease.
Rising rates of obesity and diabetes are responsible for the expected increase in steatotic liver disease (formerly nonalcoholic fatty liver disease), which currently affects more than 30% of the global population.
To help support healthy liver function, BioAdaptives has announced the development of VeganHepPlusTM, a novel, all-natural, vegan supplement formula designed to promote liver detoxification and support healthy hepatic function.
Edward Jacobs, M.D., CEO at BioAdaptives, stated, “We are very pleased to announce the development of VeganHepPlusTM, part of BioAdaptives’ strategic offering of products designed to address a wider spectrum of common health issues.
“The liver is the body’s primary filter that traps and destroys harmful threats and manufactures important nutrients and chemicals. Support for a healthy liver includes a balanced diet, adequate vitamins, minerals, and biochemical substrates that are components of critical liver enzymes and other active molecules. The rising prevalence of pesticides and other environmental pollutants underscores the importance of providing comprehensive support for this vital organ.”
VeganHepPlusTM is formulated with natural ingredients derived from Traditional Chinese Medicine and Ayurvedic culture, known to be beneficial for these symptoms. Additional ingredients with anti-aging and anti-inflammatory features fortify this formula to broaden its overall effect.
About VeganHepPlusTM
VeganHepPlusTM is an all-natural, vegan formulation containing ingredients including milk thistle, for healthy liver function, Schisandra chinensis, an anti-aging and anti-inflammatory Traditional Chinese Medicine (TCM) supplement which counters fatigue, licorice, which also exhibits anti-inflammatory properties, Fucus vesiculosis, which may protect the liver from cytokine related injury and Platycodon grandiflorus, a popular TCM herb containing fatty acids such as linoleic acid, a variety of amino acids, vitamins, and multiple essential trace elements, as well as zinc, selenium and vitamin E.
About BioAdaptives, Inc.
BioAdaptives, Inc. develops and distributes natural plant- and algal-based products that improve health and wellness for humans and animals, with an emphasis on optimizing pain relief, antiviral activity, and immune system defense; resistance to stress; endurance; recovery from injury, illness, and exercise; and anti-aging properties. The Company’s current dietary supplement formulations are carefully selected from the best sources around the world and utilize proprietary methods of enhancing the bioavailability of nutrients. BioAdaptives’ current product line includes PrimiLungs™, PluriPain®, SleepEZ™, MindnMemory™ and Cell Rejuven™ for humans. The Company’s products for horses and dogs have also demonstrated increased general health, competitive performance enhancement, rejuvenation effects, and pain relief, as well as providing improvements in appearance. BioAdaptives’ wholly owned subsidiary, LiveStock Impact, Inc markets Canine Regen All In One™, Equine All In One™ and Equine All In One Plus™ for dogs and horses. LiveStock Impact, Inc. is also positioned to develop and market botanical drugs.
BioAdaptives’ common shares trade in the OTC market under the symbol BDPT. It has over 13,000 current shareholders. None of the statements about the Company’s products have been approved by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.”
Additional information can be found at www.shopbioadaptives.com or in our SEC filings at https://www.sec.gov/cgi-bin/browse-edgar?company=bioadaptives&owner=exclude&action=getcompany
Safe Harbor Statement
This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements, trends, analysis, and other information contained in this press release including words such as "anticipate," "believe," "plan," "estimate," "expect," "intend," and other similar expressions of opinion, constitute forward-looking statements. Any such forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from any future results described within the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the Securities and Exchange Commission. The forward-looking information provided herein represents the Company's estimates as of the date of the press release, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date after the date of this press release.
Contact
Investor Relations
BioAdaptives, Inc.
(702) 659-8829
info@bioadaptives.com
Of course, this is the ultimate goal.
However, they need this news as the green light given for full working relationship with “Amazon’s Seller Center” which will be the game changer.
So far all the news we have got had no effect on pps.
Great post & realistic.
Interesting views. The news with Amazon so far has not helped at all. Share holder can’t live with just hopes and wishful thinking.
Shareholders are suffering big time, this is why previous news had no effect on pps and going down further. Show me the real meat.
Evan Gappelbery has to come with real great news to build confidence in NEXTCF/NTAR shareholders.
You can disagree with my viewpoint, no problem at all..
“I completely concur with your viewpoint”
when you have a limited time, you are working are you going to read 100-300 posts daily?
When you see all the deception, lying manipulation is going on all the time,
Are you going to read all the posts from everyone?
What are you going to learn from those people?
Only thing one can learn from certain people how to manipulate others.
Where are they now?
Most of them were flippers, traders, and shorter they made their money and gone.
They’ll come back, only when they see there is an opportunity to manipulate to make a quick buck .
I work as well too. But 4 posts?
I have absolutely no idea what is going on.
Only three posts today?
You are making sense now,
By asking to one of your master with (-D as a basher) where can you buy one of the fake stone? Lol,
This is expected behavior.
Well, thank you for telling - 1% of truth about yourself. I am sorry for you not for her.
She was very smart what she did(bravo) for dumping her.
I would have expected from you 100% that you would mislead her/anyone anyway.
You mean joining bashers group?
No thanks.
You have been a bashing since three years.
You still have not graduated from “ bashers+++ school yet?
Wow, I will give you and some of your bodies here (-D) grade.
Your masters who are here since months and weeks (D) as a failure.
Note: If you want to be a basher and manipulator you must change your school of bashers and masters.
Sorry, I did not mean ruin your confidence as a basher …
By the way, I don’t read their posts.
Why?
I know that they are not smart at all and I know what they are going to say/write.
Deja -Vue?
When I see see their names, no need to read lol.
Why to waste my energy and time to read them.
I am enjoying my Friday happy hours drinks.
Please, tell them good to see them here since they have nothing else to do every day 24/7.. We understand they need a shelter….
I am so happy the group bashers + manipulators are here tonight.
They must be very lonely that no one responding them anywhere else and they are just communicating among them selves.
Tell them… Poor you….please stay here make more mockery of yourself.
It is something up-to you. Do your own DD.
I really can’t comment on that. I got one as well which is a shareholder letter( sales pitch) with documentation of offering which I haven’t read and I wouldn’t waste my time on it.
I looked official news release and read it.
““An aggregate of up to 19,500,000 Units will be issued pursuant to National Instrument 45-106 in accordance with Part 5A thereof (the "Listed Issuer Financing Exemption") to purchasers resident in Canada, except Québec, and other jurisdictions outside of Canada.’’’’’
it’s offered only Canada except in the province of Quebec and other jurisdiction outside of Canada”
Please call them or email them to get clarification to be sure whether you are able to participate in the new offering or not & do your own proper DD.
“Following is official news release from Yahoo Finance today( Not a letter to shareholder)”.
————-
“ NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA.
TORONTO, ON / ACCESSWIRE / November 2, 2023 / Nextech3D.AI (the "Company") (OTCQX:NEXCF)(CSE:NTAR)(FSE:EP2) announces that it proposes to complete a private placement (the "Offering") pursuant to which it will issue up to 30,000,000 units ("Units") at a price of $0.12 per Unit, to raise aggregate gross proceeds of up to $3.6 million.
Each Unit will be comprised of one common share of the Company (a "Share") and one common share purchase warrant (a "Warrant"); with each whole Warrant exercisable to acquire one additional common share at a price of $0.17 for a period of 36 months from the date of issuance thereof.
An aggregate of up to 19,500,000 Units will be issued pursuant to National Instrument 45-106 in accordance with Part 5A thereof (the "Listed Issuer Financing Exemption") to purchasers resident in Canada, except Québec, and other jurisdictions outside of Canada. The Units offered under the Listed Issuer Financing Exemption will not be subject to resale restrictions pursuant to applicable Canadian securities laws. There is an offering document related to the Offering that can be accessed under the Company's profile at www.sedar.com and on the Company's website at https://www.nextechar.com/. Prospective investors should read this offering document before making an investment decision. The net proceeds from the Offering will be used for working capital and general corporate purposes. The Offering is anticipated to close on or about the week of November 22, 2023 ("Closing"), or such later date as the Company may determine. The Company may pay a finders fee of up to 8% of the gross proceeds of the Offering to eligible registrants assisting in the Offering, and issue such number of broker warrants ("Broker Warrants") as is equal to up to 8% of the number of Units sold by such registrants, with each Broker Warrant entitling the holder to acquire one Share at $0.12 for a period of 36 months.
It is anticipated that certain insiders of the Company may acquire Units under the Offering. Such participation, if any, will be considered to be a "related party transaction" within the meaning of Multilateral Instrument 61-101-Protection of Minority Security Holders in Special Transactions ("MI 61-101"). The Company intends to rely on the exemptions from the formal valuation and minority shareholder approval requirements of MI 61-101 contained in sections 5.5(a) and 5.7(1)(a) of MI 61-101 in respect of any related party participation in the Offering as neither the fair market value (as determined under MI 61-101) of the subject matter of, nor the fair market value of the consideration for, the transaction, insofar as it will involve interested parties, is expected to exceed 25% of the Company's market capitalization (as determined under MI 61-101).
The Closing is subject to certain conditions including, but not limited to, the receipt of all necessary regulatory and other approvals, including the approval of the Canadian Securities Exchange.
This news release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful, including any of the securities in the United States of America. The securities described herein have not been and will not be registered under the United States Securities Act of 1933, as amended (the "1933 Act") or any state securities laws and may not be offered or sold within the United States or to, or for account or benefit of, U.S. Persons (as defined in Regulation S under the 1933 Act) unless registered under the 1933 Act and applicable state securities laws, or an exemption from such registration requirements is available.
About Nextech3D.ai
The Company is a diversified augmented reality, AI technology company that leverages proprietary artificial intelligence (AI) to create 3D experiences for the metaverse. Its main businesses are creating 3D WebAR photorealistic models for the Prime Ecommerce Marketplace as well as many other online retailers. The Company develops or acquires what it believes are disruptive technologies and once commercialized, spins them out as stand-alone public companies issuing a stock dividend to shareholders while retaining a significant ownership stake in the public spin-out.
On October 26, 2022, the Company spun out its spatial computing platform, "ARway.ai" as a stand alone public company. ARway.ai is disrupting the augmented reality wayfinding market with a no-code, no beacon spatial computing platform enabled by visual marker tracking. The Company retained 13 million shares in ARway and distributed 4 million shares to Nextech3D.AI shareholders. ARway.ai is currently listed on the Canadian Securities Exchange (CSE:ARWY), in USA on the OTCQB (OTCQB:ARWYF) and Internationally on the Frankfurt Stock Exchange (FSE:E65).
On June 14, 2023, the Company completed its second spinout of Toggle3D.ai, a groundbreaking SaaS solution that utilizes generative AI to convert CAD files, apply stunning 4K texturing, and enable seamless publishing of superior 4K 3D models. The Company retained 13 million shares in Toggle3D.ai and distributed 4 million shares to Nextech3D.AI shareholders. Toggle3D.ai is trading on the Canadian Securities Exchange (CSE:TGGL) and in the USA (OTCQB:TGGLF).
To learn more visit our website: https://www.nextechar.com.
For further information, please contact:
Investor Relations Contact
Julia Viola
investor.relations@Nextechar.com
Nextech3D.AI
Evan Gappelberg
CEO and Director
866-ARITIZE (274-8493)
Disclaimer for Forward-Looking Information
This news release includes certain statements and information that constitute forward-looking information within the meaning of applicable Canadian securities laws. All statements in this news release, other than statements of historical facts are forward-looking statements. Such forward-looking statements and forward-looking information specifically include, but are not limited to, statements that relate to the anticipated size and timing of Offering, insider participation in the Offering, and the receipt of all applicable approvals in connection therewith.
Statements contained in this release that are not historical facts are forward-looking statements that involve various risks and uncertainty affecting the business of the Company. Such statements can generally, but not always, be identified by words such as "expects", "plans", "anticipates", "intends", "estimates", "forecasts", "schedules", "prepares", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. All statements that describe the Company's plans relating to operations and potential strategic opportunities are forward-looking statements under applicable securities laws. These statements address future events and conditions and are reliant on assumptions made by the Company's management, and so involve inherent risks and uncertainties, as disclosed in the Company's periodic filings with Canadian securities regulators. As a result of these risks and uncertainties, and the assumptions underlying the forward-looking information, actual results could materially differ from those currently projected, and there is no representation by the Company that the actual results realized in the future will be the same in whole or in part as those presented herein. The Company disclaims any intent or obligation to update forward-looking statements or information except as required by law. Readers are referred to the additional information regarding the Company's business contained in the Company's reports filed with the securities regulatory authorities in Canada. Although the Company has attempted to identify important factors that could cause actual actions, events, or results to differ materially from those described in forward-looking statements, there may be other factors that could cause actions, events or results not to be as anticipated, estimated or intended. For more information on the Company and the risks and challenges of its business, investors should review the Company's filings that are available at www.sedar.com.
The Company provides no assurance that forward-looking statements and information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements or information. Accordingly, readers should not place undue reliance on forward-looking statements or information. The Company does not undertake to update any forward-looking statements, other than as required by law. “
SOURCE: Nextech3D.ai
“An aggregate of up to 19,500,000 Units will be issued pursuant to National Instrument 45-106 in accordance with Part 5A thereof (the "Listed Issuer Financing Exemption") to purchasers resident in Canada, except Québec, and other jurisdictions outside of Canada. The Units offered under the Listed Issuer Financing Exemption will not be subject to resale restrictions pursuant to applicable Canadian securities laws. There is an offering document related to the Offering that can be accessed under the Company's profile at www.sedar.com and on the Company's website at https://www.nextechar.com/“
Please, do your own DD to get accurate information.
Well, USA shareholder with Quebec residents wouldn’t get this deep discounted offering of new offering with warrants. Of course, management is entitled for 10%, lol.
Do what is best for you.
Bullies are back with intimidation, manipulation tactics. They are playing psycollcial welfare games with you.
Make sure you do your own proper DD’s through SEC web page. They will change some wordings you will have hard time to find out.
The best reliable source for infos is SEC webpage.
Agree 100 %.
Some people have low morale standards with no ethical dilemma.
When one’s morale compass is broken they do anything possible just to win.
For some lying, cheating, spinning wrong informations, hurting others is normal. This is what they are trained to do and they are going to keep doing it. They are very well aware of what they are doing.
For them it is victory, because they got nothing else matter in their life.
Why answer them?
Why to go to their level? It is exactly what they want to challenge you to wrestle in the mud.
They should have read “ Steven Covey’s” book to learn what is morale compass.
Please, don’t play angel game.
You were one of the pumpers as well from time to time. You were changing sides whether you are long, short or wanted to buy cheaper.
Why do you thing you are giving bid and offer prices regularly?
Create more panic?, IMO
Perhaps dilution started before year end?
And a few short seller acknowledged they are shortening as well.
Agree 250 %.
Agree 100 %
Oh, great u posted both of them.
I was not available today, work….
I have to read some posts now, good thing is not to many these days after ignoring some characters posts…lol.
Fridays happy hours good time to read.
Excellent letter. Thanks for taking the initiative writing to them and been in contacts with them.
I remember they responded to you a few times months ago. Let hope you get a positive response which will be good enough for all of us.
Yes, I am a shareholder.
However, under no circumstances I will recommend, any stocks here including BDPT as a
Buy, Sell or Hold. Do your own DDs and know your risk tolerance/see a qualified investment advisor.
Look into misrepresentation and playing the words.
An option to purchase has been interpret to you as paid(cost) $400,000.
IMO, this is manipulation.
“Let's unpack that, shall we. It is a 2-year licensing agreement. It cost $400,000. Mohr is paid an additional monthly stipend. Fancy water has been "sold" now for 20 months, with only 4 months left to go before the license expires. The company has not made anywhere close to $400,000 in sales to recoup this FANTASTIC investment”
Fear mongering at its best.
The company( BDPT) has not paid
$400,000 for the patent yet. It is clear and explicitly written “option”.
Reading &understanding one thing, but misrepresentation is a manipulation.
The option to buy does not mean paid
$400,000. All it is BDPT has an option to purchase. IMO they are going to walk away or they extend, change the agreement
prior 2/2/2024. IMO…
“Effective February 2, 2022, the Company entered into a Patent Purchase Agreement and Consulting Agreement with Thomas J. Mohr. Under the Agreement, the Company has the exclusive option to purchase Mohr’s U.S. Patent No. 9,783,432B (the “Patent”), which covers technology used in enhancing the capability of water to hold significantly larger amounts of oxygen, for a two-year period. The option price is $400,000. The Agreement furthermore allows the Company a two-year license to use the technology covered by the Patent, including for further development of oxygenated water products for consumers. In exchange for the license, the Company will pay Mohr a royalty, scaled to total product sales. “
You are so right. This why you can buy Wallmart at .0012?
Please, let us know on which exchange are you buying them, lol.
This is an immense marketing and partnership opportunity for expected $100 billion revenue for this disease around the globe.
Their solution for this is NATURAL REMEDY.
Agree 100%.
This is not what we are expecting now however, this is not fluff either.
“We are targeting a slice of the global sleep aid market which was valued at $59 billion in 2020 and is projected to reach $111 billion by 2023.”
We know who you are. You proved yourself extremely unreliable and dangerous on this board the last 3-4 months.
Do you want us to repost your comments here again?
Absolutely, look what is pumping now.
No company open their doors to be in the business to educate people. All they can do put a messages, filings there, let people read and interpret the news themselves.
The problem is we became very news dependent and we call our self long term share holder when we can’t flip a stock after a week.
We listen to many “gurus?” accept their their positive and negative thoughts while they have different agenda “ manipulation” and after a while confirmation bias has started which became our realty of real thoughts, what a pity( we are not aware we have been manipulated by those gurus.
Flippers are disappeared. I believe long term shareholders are here, just quite.
Exactly.
I agree 100%, I am here to make good $$, and I will be waiting for quite a few news and further developments, I don’t want to react to price fluctuations.
I am wondering how some people feel today, when they got in from .80 to .96 last night?
This prices may help R/S to qualify for Nasdaq listing again which will be discussed in shareholder meeting next week, IMO.
Guten Morgen/ Good morning all